Biofrontera Inc - Warrants (27/10/2026)
BFRIW
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.96M
Close$
$-0.25
827.1% downside
Current Fair Value
827.1% downsideOvervalued by 827.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.96 Million |
|---|---|
| Enterprise Value | $15.36 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.04 |
| Beta | 0.83 |
| Outstanding Shares | 11,683,323 |
Return
| Return on Equity | -182.62% |
|---|---|
| Return on Assets | -44.72% |
| Return on Invested Capital | -82.03% |
Valuation & Multiples
| P/E Ratio | -0.97 |
|---|---|
| PEG | -7.45 |
| Price to Sales | 0.01 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.36 |
| Enterprise Value to EBIT | -1.35 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 1.27 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$10.25 M
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$9.50 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data